Inozyme Pharma Inc (NAS:INZY) Stock News, Headlines & Updates
Inozyme Pharma Inc Stock News from GuruFocus
- 1
Jul 02, 2024
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
Marketwired • 8:00am
Jun 21, 2024
Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children's Bone Health (ICCBH)
Marketwired • 12:00pm
May 30, 2024
Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
Marketwired • 8:00am
May 23, 2024
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
Marketwired • 8:00am
May 08, 2024
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
Marketwired • 8:00am
May 07, 2024
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
Marketwired • 8:00am
May 03, 2024
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news